Almost one in four skin biopsies is melanocytic proliferation

November 3, 2017

(HealthDay)—About one-quarter of skin biopsies are diagnosed as melanocytic proliferation, according to a study published online Nov. 1 in JAMA Dermatology.

Jason P. Lott, M.D., from Cornell Scott-Hill Health Center in New Haven, Connecticut, and colleagues examined the frequencies and distribution of histologically confirmed melanocytic lesions by conducting a natural language processing-based analysis of electronic medical record pathology reports of adult patients who underwent biopsies. The authors examined 80,368 skin biopsies performed on 47,529 patients.

The researchers found that 23 percent of skin biopsies were of melanocytic lesions. Based on the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis, 83.1, 8.3, 4.5, 2.2, and 1.9 percent of lesions were I (nevi and other benign proliferations such as mildly dysplastic lesions usually requiring no further treatment), class II (moderately dysplastic and other low-risk lesions), class III (melanoma in situ and other higher-risk ), class IV, and class V (for class IV/V: invasive melanoma requiring wide re-excision and potential adjunctive therapy), respectively.

"Approximately one-quarter of skin biopsies resulted in diagnoses of melanocytic proliferations. These data provide the first population-based estimates across the spectrum of ranging from benign through dysplastic to malignant," the authors write. "These results may serve as a foundation for future research seeking to understand the epidemiology of melanocytic proliferations and optimization of skin utilization."

One author is an employee of Bayer US LLC.

Explore further: Study raises concern over accuracy of melanoma diagnoses

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Study raises concern over accuracy of melanoma diagnoses

June 28, 2017
Concerns over the accuracy of melanoma diagnoses are raised in a study of US pathologists published by The BMJ today.

Pathologists vary in suggested therapy for melanocytic lesions

December 20, 2016
(HealthDay)—Pathologists have wide variability in treatment suggestions for melanocytic lesions, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

Negative pigment network able to distinguish melanoma

October 25, 2012
(HealthDay)—Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.

Malpractice concerns affect derm-path interpretive behavior

February 1, 2016
(HealthDay)—Many dermatopathologists believe that malpractice concerns may lead to additional testing in their evaluation of cutaneous melanocytic lesions, according to research published in the February issue of the Journal ...

Suspicious pigment spots more common on darker skin

December 14, 2015
(HealthDay)—People with darker skin are about one-third more likely to have potentially dangerous pigment "spots" on their palms and soles, a new study finds.

Cancer researchers discover gene defect responsible for cancer syndrome

September 6, 2012
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.